Literature DB >> 24703100

Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.

Enrico Munari1, Luigi Marchionni2, Apurva Chitre2, Masamichi Hayashi3, Guido Martignoni4, Matteo Brunelli5, Stefano Gobbo4, Pedram Argani1, Mohamad Allaf6, Mohammad O Hoque7, George J Netto8.   

Abstract

Clear cell papillary renal cell carcinoma (CCPRCC) is a low-grade renal neoplasm with morphological characteristics mimicking both clear cell renal cell carcinoma (CCRCC) and papillary renal cell carcinoma (PRCC). However, despite some overlapping features, their morphological, immunohistochemical, and molecular profiles are distinct. Micro-RNAs (miRNAs) are small noncoding RNAs that play a crucial role in regulating gene expression and are involved in various biological processes, including cancer development. To better understand the biology of this tumor, we aimed to analyze the miRNA expression profile of a set of CCPRCC using microarray and quantitative reverse transcription-polymerase chain reaction. A total of 15 cases diagnosed as CCPRCC were used in this study. Among the most differentially expressed miRNA in CCPRCC, we found miR-210, miR-122, miR-34a, miR-21, miR-34b*, and miR-489 to be up-regulated, whereas miR-4284, miR-1202, miR-135a, miR-1973, and miR-204 were down-regulated compared with normal renal parenchyma. To identify consensus of differentially regulated miRNA between CCPRCC, CCRCC, and PRCC, we additionally determined differential miRNA expression using 2 publically available microarray data sets from the NCBI Gene Expression Omnibus database (GSE41282 and GSE3798). This comparison revealed that the miRNA expression profile of CCPRCC shows some overlapping characteristics between CCRCC and PRCC. Moreover, CCPRCC lacks dysregulation of important miRNAs typically associated with aggressive behavior. In summary, we describe the miRNA expression profile of a relatively infrequent type of renal cancer. Our results may help in understanding the molecular underpinning of this newly recognized entity.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clear cell papillary renal cell carcinoma; Micro-RNA; Profiling; Renal cancer

Mesh:

Substances:

Year:  2014        PMID: 24703100      PMCID: PMC4332813          DOI: 10.1016/j.humpath.2014.01.013

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  33 in total

1.  Accurate molecular classification of kidney cancer subtypes using microRNA signature.

Authors:  Youssef M Youssef; Nicole M A White; Jörg Grigull; Adriana Krizova; Christina Samy; Salvador Mejia-Guerrero; Andrew Evans; George M Yousef
Journal:  Eur Urol       Date:  2011-01-13       Impact factor: 20.096

2.  Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biology.

Authors:  A Rose Brannon; Scott M Haake; Kathryn E Hacker; Raj S Pruthi; Eric M Wallen; Matthew E Nielsen; W Kimryn Rathmell
Journal:  Eur Urol       Date:  2011-10-18       Impact factor: 20.096

3.  Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins.

Authors:  Stephen M Rohan; Yonghong Xiao; Yupu Liang; Maria E Dudas; Hikmat A Al-Ahmadie; Samson W Fine; Anuradha Gopalan; Victor E Reuter; Marc K Rosenblum; Paul Russo; Satish K Tickoo
Journal:  Mod Pathol       Date:  2011-05-20       Impact factor: 7.842

Review 4.  MicroRNA-210: a unique and pleiotropic hypoxamir.

Authors:  Stephen Y Chan; Joseph Loscalzo
Journal:  Cell Cycle       Date:  2010-03-15       Impact factor: 4.534

5.  Molecular classification of adult renal epithelial neoplasms using microRNA expression and virtual karyotyping.

Authors:  Martin P Powers; Karla Alvarez; Hyun-Jung Kim; Federico A Monzon
Journal:  Diagn Mol Pathol       Date:  2011-06

6.  miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.

Authors:  Nicole M A White; Tian Tian Bao; Jörg Grigull; Youssef M Youssef; Andrew Girgis; Maria Diamandis; Eman Fatoohi; Maged Metias; R John Honey; Robert Stewart; Kenneth T Pace; Georg A Bjarnason; George M Yousef
Journal:  J Urol       Date:  2011-07-23       Impact factor: 7.450

7.  The VHL-dependent regulation of microRNAs in renal cancer.

Authors:  Calida S Neal; Michael Z Michael; Lesley H Rawlings; Mark B Van der Hoek; Jonathan M Gleadle
Journal:  BMC Med       Date:  2010-10-21       Impact factor: 8.775

8.  The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response.

Authors:  Leandro Castellano; Georgios Giamas; Jimmy Jacob; R Charles Coombes; Walter Lucchesi; Paul Thiruchelvam; Geraint Barton; Long R Jiao; Robin Wait; Jonathan Waxman; Gregory J Hannon; Justin Stebbing
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

9.  Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 associate with clear cell renal cell carcinoma.

Authors:  Liang Zhou; Jiahao Chen; Zhizhong Li; Xianxin Li; Xueda Hu; Yi Huang; Xiaokun Zhao; Chaozhao Liang; Yong Wang; Liang Sun; Min Shi; Xiaohong Xu; Feng Shen; Maoshan Chen; Zujing Han; Zhiyu Peng; Qingna Zhai; Jing Chen; Zhongfu Zhang; Ruilin Yang; Jiongxian Ye; Zhichen Guan; Huanming Yang; Yaoting Gui; Jun Wang; Zhiming Cai; Xiuqing Zhang
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

10.  MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy.

Authors:  Monika Jung; Hans-Joachim Mollenkopf; Christina Grimm; Ina Wagner; Marco Albrecht; Tobias Waller; Christian Pilarsky; Manfred Johannsen; Carsten Stephan; Hans Lehrach; Wilfried Nietfeld; Thomas Rudel; Klaus Jung; Glen Kristiansen
Journal:  J Cell Mol Med       Date:  2009-02-17       Impact factor: 5.310

View more
  24 in total

1.  Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma.

Authors:  Nur P Damayanti; Justin A Budka; Heba W Z Khella; Mary W Ferris; Sheng Yu Ku; Eric Kauffman; Anthony C Wood; Khunsha Ahmed; Venkata Nithinsai Chintala; Remi Adelaiye-Ogala; May Elbanna; Ashley Orillion; Sreenivasulu Chintala; Chinghai Kao; W Marston Linehan; George M Yousef; Peter C Hollenhorst; Roberto Pili
Journal:  Clin Cancer Res       Date:  2018-07-30       Impact factor: 12.531

Review 2.  The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome.

Authors:  Francesco Massari; Chiara Ciccarese; Ondrej Hes; Michal Michal; Anna Caliò; Michelangelo Fiorentino; Francesca Giunchi; Alessandro D'Amuri; Francesca Sanguedolce; Roberto Sabbatini; Annalisa Guida; Andrea Ardizzoni; Camillo Porta; Roberto Iacovelli; Giampaolo Tortora; Luca Cima; Cinzia Ortega; Alberto Lapini; Guido Martignoni; Matteo Brunelli
Journal:  Pathol Oncol Res       Date:  2017-07-10       Impact factor: 3.201

3.  A microRNA signature in pediatric ulcerative colitis: deregulation of the miR-4284/CXCL5 pathway in the intestinal epithelium.

Authors:  Georgios Koukos; Christos Polytarchou; Jess L Kaplan; Angelos Oikonomopoulos; David Ziring; Daniel W Hommes; Renaisa Wahed; Efi Kokkotou; Charalabos Pothoulakis; Harland S Winter; Dimitrios Iliopoulos
Journal:  Inflamm Bowel Dis       Date:  2015-05       Impact factor: 5.325

4.  MiR-1202 Exerts Neuroprotective Effects on OGD/R Induced Inflammation in HM Cell by Negatively Regulating Rab1a Involved in TLR4/NF-κB Signaling Pathway.

Authors:  Shuhuan Song; Yan Pan; Hua Li; Honghua Zhen
Journal:  Neurochem Res       Date:  2020-03-02       Impact factor: 3.996

5.  MicroRNA expression profiling of Xp11 renal cell carcinoma.

Authors:  Luigi Marchionni; Masamichi Hayashi; Elisa Guida; Akira Ooki; Enrico Munari; Fayez J Jabboure; Wikum Dinalankara; Ali Raza; George J Netto; Mohammad O Hoque; Pedram Argani
Journal:  Hum Pathol       Date:  2017-04-12       Impact factor: 3.466

6.  MicroRNA-489 Induction by Hypoxia-Inducible Factor-1 Protects against Ischemic Kidney Injury.

Authors:  Qingqing Wei; Yong Liu; Pengyuan Liu; Jielu Hao; Mingyu Liang; Qing-Sheng Mi; Jian-Kang Chen; Zheng Dong
Journal:  J Am Soc Nephrol       Date:  2016-03-14       Impact factor: 10.121

Review 7.  Renal Carcinogenesis, Tumor Heterogeneity, and Reactive Oxygen Species: Tactics Evolved.

Authors:  Karthigayan Shanmugasundaram; Karen Block
Journal:  Antioxid Redox Signal       Date:  2016-07-27       Impact factor: 8.401

Review 8.  Molecular genetics and immunohistochemistry characterization of uncommon and recently described renal cell carcinomas.

Authors:  Qiu Rao; Qiu-Yuan Xia; Liang Cheng; Xiao-Jun Zhou
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

9.  Endogenous miR-204 Protects the Kidney against Chronic Injury in Hypertension and Diabetes.

Authors:  Yuan Cheng; Dandan Wang; Feng Wang; Jing Liu; Baorui Huang; Maria Angeles Baker; Jianyong Yin; Rui Wu; Xuanchen Liu; Kevin R Regner; Kristie Usa; Yong Liu; Congxiao Zhang; Lijin Dong; Aron M Geurts; Niansong Wang; Sheldon S Miller; Yongcheng He; Mingyu Liang
Journal:  J Am Soc Nephrol       Date:  2020-06-02       Impact factor: 14.978

10.  MicroRNA-210 induces apoptosis in colorectal cancer via induction of reactive oxygen.

Authors:  Katrin E Tagscherer; Anne Fassl; Tabea Sinkovic; Jutta Richter; Sabrina Schecher; Stephan Macher-Goeppinger; Wilfried Roth
Journal:  Cancer Cell Int       Date:  2016-06-10       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.